Tradestie Institutional Equity Comparison Engine

AKRO vs ALEC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALEC Overall Edge

ALEC Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alector, Inc. Common Stock (ALEC) driven by superior Valuation, Growth & Margin, Options & Structure while AKRO counters with relative strength in Momentum & Technical. Fundamentally, AKRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ALEC at 8.5x Forward P/E and 21.8% operating margin (+4895.9% YoY). In options structure, AKRO sits in UNCLASSIFIED (30th %ile IV; Dealer Gamma Walls on Pro) against ALEC sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ALEC
AKRO N/M vs ALEC 8.5x Fwd P/E
Growth & Margin Winner ALEC
Op Margin 0.0% vs 21.8% ยท YoY +0.0% vs +4895.9%
Momentum & Technical Winner AKRO
1Y +76.8% vs +91.4% ยท 52W Pos 90% vs 71%
Options & Structure Winner ALEC
UNCLASSIFIED (30th %ile IV) vs CONSOLIDATION (18th %ile IV)
AKRO NASDAQ
Akero Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$54.65
+0.32% 1D
Market Cap $4.5B
1M Return +1.37%
1Y Return +76.75%
Forward P/E N/M
Unified AI Score
60.0 / 100 BUY
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
ALEC NASDAQ
Alector, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.33
+1.52% 1D
Market Cap $342.4M
1M Return +27.6%
1Y Return +91.39%
Forward P/E 8.5x
Unified AI Score
52.1 / 100 HOLD
Tech 39.0 Fund 52.0 Flow 72.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AKRO +76.75% ALEC +91.39% Spread: +0.57 pp (AKRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AKRO TTM Op. Margin: 0.0% ALEC TTM Op. Margin: 21.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKRO vs ALEC. Trailing 12-month operating profitability (AKRO 0.0% vs ALEC 21.8%) and valuation multiples (AKRO N/M vs ALEC 8.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AKRO (4) vs ALEC (6)
Institutional Metric AKRO ALEC Criterion Row Winner
Market Capitalization Scale $4.5B $342.4M Larger Scale AKRO
Trailing P/E Ratio Valuation N/M 6.2x Lower Multiple ALEC
Forward P/E Ratio Valuation N/M 8.5x Lower Multiple ALEC
Revenue Growth (YoY) Growth +0.0% +4895.9% Higher Growth ALEC
Operating Margin (TTM) Profitability 0.0% 21.8% Higher Margin ALEC
Net Profit Margin Profitability 0.0% 23.9% Higher Margin ALEC
Return on Equity (ROE) Capital Efficiency -34.5% 47.5% Higher ROE ALEC
52-Week Range Position Momentum 90% ($21โ€“$58) 71% ($1โ€“$3) Stronger Trend AKRO
Beta / 30D Volatility Risk Regime 0.90ฮฒ ยท 2% Vol 1.53ฮฒ ยท 98% Vol Lower Realized Risk AKRO
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 52.1 / 100 (HOLD) Higher Composite AKRO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AKRO vs ALEC Buy Guide
AKRO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AKRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALEC CONSOLIDATION
56d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ALEC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AKRO nor ALEC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.